181 related articles for article (PubMed ID: 11257342)
1. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).
Niewiesk S
Vaccine; 2001 Mar; 19(17-19):2250-3. PubMed ID: 11257342
[TBL] [Abstract][Full Text] [Related]
2. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
3. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
[TBL] [Abstract][Full Text] [Related]
5. Cotton rats (Sigmodon hispidus): an animal model to study the pathogenesis of measles virus infection.
Niewiesk S
Immunol Lett; 1999 Jan; 65(1-2):47-50. PubMed ID: 10065626
[TBL] [Abstract][Full Text] [Related]
6. Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
Pasetti MF; Ramirez K; Resendiz-Albor A; Ulmer J; Barry EM; Levine MM
J Virol; 2009 Mar; 83(6):2789-94. PubMed ID: 19129445
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
Schlereth B; Germann PG; ter Meulen V; Niewiesk S
J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
[TBL] [Abstract][Full Text] [Related]
8. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
[TBL] [Abstract][Full Text] [Related]
9. Current animal models: cotton rat animal model.
Niewiesk S
Curr Top Microbiol Immunol; 2009; 330():89-110. PubMed ID: 19203106
[TBL] [Abstract][Full Text] [Related]
10. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats.
Kim D; Niewiesk S
Vaccine; 2014 Jan; 32(2):265-70. PubMed ID: 24262312
[TBL] [Abstract][Full Text] [Related]
12. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
13. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
14. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
Julik E; Reyes-Del Valle J
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
[TBL] [Abstract][Full Text] [Related]
16. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
[TBL] [Abstract][Full Text] [Related]
17. Use of cotton rats for preclinical evaluation of measles vaccines.
Wyde PR; Stittelaar KJ; Osterhaus AD; Guzman E; Gilbert BE
Vaccine; 2000 Aug; 19(1):42-53. PubMed ID: 10924785
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
19. Sidestepping maternal antibody: a lesson from measles virus vaccination.
Kim D; Niewiesk S
Expert Rev Clin Immunol; 2011 Sep; 7(5):557-9. PubMed ID: 21895466
[No Abstract] [Full Text] [Related]
20. [A study on the level of antibody against measles through maternal-fetal transfer and the immuno-response to measles vaccine among 4 to 7 month olds].
Liu BY; Feng ZX; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):263-5. PubMed ID: 8706090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
